Category Archives: Economics of Innovation

Subscribe to Economics of Innovation RSS Feed

DESPITE BARRIERS, COMMUNITY SPECIALTY CLINICIANS ARE EAGER TO ADOPT PRECISION MEDICINE TOOLS

Reimbursement-Icon-Light
GUEST POST BY Vicki Albrecht, Ph.D., Senior Vice President and General Manager of ION Solutions Fueled by technological advances, scientific breakthroughs and significant financial investments, precision medicine (PM) has emerged as a promising approach to disease prevention and treatment. A multi-faceted solution to patient care, PM can improve patient outcomes and increase the effectiveness of … Continue reading this entry

AmerisourceBergen Guest Post: Solutions to Overcome Reimbursement Challenges in Personalized Medicine

ABC Logo - Copy
Guest Post by Amy Grogg, PharmD, Senior Vice President of Strategy and Commercialization, AmerisourceBergen Specialty Group The continued development and refinement of personalized medicine (PM) has offered an opportunity to revolutionize medical practice and improve outcomes by providing treatments for patients with the notion that “this drug is for you.” The promise of personalized medicine … Continue reading this entry

Unlocking the Promise of Personalized Medicine: Reimbursement, Coverage, and Clinical Utility

243x200BPM
AmerisourceBergen, in connection with the Business of Personalized Medicine Summit, released “Unlocking the Promise of Personalized Medicine: Perspectives on Reimbursement, Coverage, and Clinical Utility” (“Report“). The Report explores the role of personalized medicine in today’s health care system with an overview of payer perspectives and provides recommendations to innovators to navigate the path to commercialization of … Continue reading this entry

Clinical Adoption of Personalized Medicine

A recent study published in the American Journal of Medical Genetics, “Barriers for Integrating Personalized Medicine into Clinical Practice:  A Qualitative Analysis” investigated physicians’ perceptions about the future of personalized medicine and identified factors that would influence their decisions in using genetic testing in their practice. The study is an interesting read for any innovator … Continue reading this entry

Business Models for Personalized Medicine

Personalized medicine is moving from concept to reality, fueled in part by advances in sequencing technology and data analysis. However, significant business challenges remain that hinder growth and adoption of personalized health care. One such challenge how to is pay for the research and development of new diagnostics and therapies when the target patient population does not … Continue reading this entry

Patent Pool Simplifies Development of Personalized Medicine

One argument often cited against patenting is that multiple patents can cover one product, its preparation and use, creating a so-called “patent thicket” that must be unwound like a bowl of spaghetti before a new technology is free of potential liability. Cooperation and collaboration among patent holders in the form of a patent pool is one means … Continue reading this entry

The Economics of Innovation: Part II

In my June 10th, 2012 post, I  noted a report on the current debate whether or not patents promote or impair innovation in the diagnostic field.  Last week at the 2012 Biotechnology International Organization (BIO) International Convention, Joseph Damond, vice-president for international affairs at BIO reported… Continue reading this entry